Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03824808 · ClinicalTrials.gov registry record · Phase 4
Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery
A Phase 4 study, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT03824808 is a Phase 4 study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 21 participants.
The verdict
NCT03824808, a Phase 4 study, was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
Controlling pain is fundamental during and after surgical procedures. This study examines pain associated with robotic assisted surgery on prostate cancer or a kidney mass. In recent years, the risk of opioids in the postoperative period has gained interest due to the growing epidemic of addiction, dependence, and overdose. In this study, the investigators expect a continuous infusion of intravenous lidocaine during the perioperative period to result in less pain and less opioid use.
Interventions
- DRUG 0.9% Sodium Chloride Injection
- DRUG Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-02-26 |
| Est. Completion | 2020-03-26 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03824808
The ClinicalTrials.gov registry entry for NCT03824808 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 0.9% Sodium Chloride Injection is the first listed.
NCT03824808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03824808 about?
NCT03824808 is a clinical study titled "Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery". Controlling pain is fundamental during and after surgical procedures. This study examines pain associated with robotic assisted surgery on prostate cancer or a kidney mass. In recent years, the risk of opioids in the postoperative period has gained interest due to the growing epidemic of addiction, ...
What is the current status of trial NCT03824808?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2019-02-26. Estimated completion is 2020-03-26.
What interventions are being tested in trial NCT03824808?
The interventions under investigation include: 0.9% Sodium Chloride Injection (DRUG), Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution (DRUG).
Who is sponsoring clinical trial NCT03824808?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.